Trial Search Results

Non-Myeloablative Allogeneic Transplant for Myelodysplastic Syndromes and Myeloproliferative Disorders

To improve survival outcomes for patients with MDS and MPD with a nonmyeloablative allogeneic hematopoietic cell transplant.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Collaborator: National Institutes of Health (NIH)

Stanford Investigator(s):

Intervention(s):

  • Procedure: nonmyeloablative allogeneic hematopoietic cell transplant

Phase:

N/A

Eligibility


Inclusion Criteria:- Myelodysplastic Syndromes

   - Myeloproliferative Disorders

   - HLA matched donor available Exclusion Criteria:- organ dysfunction

   - HIV positive

Ages Eligible for Study

18 Years - 75 Years

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
BMT Referrals
6507230822
Not Recruiting